Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × Therapeutics × 1 year × Clear all

Sponsor

Conditions

Neoplasms 9 Depression 7 Breast Neoplasms 7 Prostatic Neoplasms 6 Neoplasm Metastasis 5 Lymphoma, Follicular 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Colorectal Neoplasms 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thrombocythemia, Essential 1 Substance-Related Disorders 1

Interventions

pembrolizumab 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Carboplatin 5 Docetaxel 4 Biopsy 4 trastuzumab deruxtecan 3 darolutamide 3 Trastuzumab 3 Platinum 3 Goserelin 3 Cisplatin 3 sacituzumab govitecan 2 pertuzumab 2 entrectinib 2 Leuprolide 2 Ado-Trastuzumab Emtansine 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 trastuzumab biosimilar HLX02 1 spartalizumab 1 selinexor 1 pyrotinib 1 luprolide acetate gel depot 1 lenvatinib 1 larotrectinib 1 enfortumab vedotin 1 dehydroftorafur 1 ceralasertib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡